Current Landscape Challenges
Patent Cliff and Competition
$300B+ at risk by 2030 from loss of exclusivity
Maximize patent value (LCM) + expand indications
Erosion drivers: LOE, biosimilars/generics, pricing pressure
Pricing and Payer Pressure
Pricing & access = top risk
Policy pressure: IRA + tougher EU HTA
Action: accelerate payer-grade RWE to secure coverage
AI Imperative
AI is a priority and are accelerating real-world evidence programs. Missing the AI/ RWE wave risks falling behind.
Regional Market Access Challenges
United States
-
complex payer landscape with multiple formularies
-
IRA drug price negotiations changing market dynamics
-
increasing demand for real word evidence
-
competitive market requiring rapid launch execution
Canada
-
Average over 598 day wait for public formulary listing
-
Provincial review process adding complexity
-
PMPRB regulations affecting pricing strategy
-
Smaller market requiring specialized approach
European Union
-
More countries with greater than 1 year access delays
-
Stringent HTA requirements change by country
-
Risk averse capital environment
-
GDPR compliance adding complexity
Therapeutic Challenges
United States
Canada
AI Data and ROI Concerns
-
Challenge
-
Regulatory and compliance concerns
-
Market access and launch barriers
-
Operational and adoption risk
-
Financial and strategic concerns
-
Cultural and trust issues
-
-
SGAI Approach
-
Launch Compression Frameworks
-
Regulatory-Ready AI
-
Integration Blueprints
-
Education & Change Management
-
Investor-Grade Metrics
-
Partnership Hurdles
-
Challenge
-
Internal skills gaps
-
Slow vendor onboarding
-
Regulatory and compliance
-
System integration
-
Cost / benefit
-
Time and personnel allocation
-
-
SGAI Approach
-
Compliance built in to everything we do
-
Experienced professionals
-
Fractional leadership
-
SGAI academy
-
AI Benefits
Core Capabilities
Strategic Growth AI empowers pharmaceutical companies to turn strategic focus into execution
Commercial Acceleration
-
Driving faster more efficient launches
-
AI enabled sales targetting
-
Streamlined launch frameworks
-
Orchestrated omnichannel engagement with HCP
Market Access
-
Designing pathways that align payer and HTA
-
Dossiers
-
Budget
-
Outcome agreements
-
Tender readiness
Compliance and Security
-
Building audit ready future proof compliance
-
AI driven regulatory intelligence
-
Proactive cybersecurity
-
Adaptable global frameworks
Clinical Pipeline Efficiency
-
Enhancing trial performance and discovery timelines
-
Predictive site scoring
-
Real time risk detection
-
Partnerships that accelerate discovery
-
AI enabled platforms
Patient Outcomes
-
Improving adherence engagement
-
Digital therapeutics integration
-
Digital first patient support programs
-
Outcome tracking with payer and regulatory expectations
IT and Digital
-
AI-Enhanced Commercialization & Market Access
-
Digital Patient & HCP Engagement Built to Scale
-
AI Implementation & Training for Pharma Teams
-
AI solutions for clinical and PSP
Board / C-Suite Concerns
Patent Cliff & Revenue Erosion
SGAI Helps
Lifecycle extension strategies from digital persistence programs to indication expansion modeling and use AI-driven forecasting to defend revenue through the patent cliff.
Commercial & Market Access
SGAI Helps
AI-driven omnichannel, real-world evidence, and HCP training turning standard engagement into measurable, scalable impact.
Pipeline Costing and Clinical Risk
SGAI Helps
I-enabled solutions to assist trial optimization, predictive site selection, and risk monitoring shorten timelines, reduce attrition, and improve probability of success.
Regulatory Compliance Exposure
SGAI Helps
Audit-ready compliance, automated risk alerts, and secure digital frameworks to safeguard approvals and protect against fines and reputational damage
Key Stakeholder Messaging
C-Suite
Protect and Grow Revenue
Market Access
Accelerate coverage and formulary wins
Sales and Marketing
Drive adoption and gain competitive advantage
R&D Medical Affairs
Enhance scientific credibility and accelerate evidence
Legal and Compliance
Mitigate risk and speed approval
IT and Digital
Seamless and compliant integration
Why Work With Us?
Micro-disclaimer:
Information is general and not a substitute for advice from qualified legal, regulatory, or medical professionals. Regulatory and payer outcomes are independent and not guaranteed. Clarity AI provides business scenario planning only.